French company Carmat has unveiled the first human artificial heart implant in the United States recently as part of a clinical study.
According to the company’s website, a complete artificial heart called Aeson is already available in Europe.
This “first US-based clinical trial will be crucial for development in the world’s largest market – medical equipment“, Stephen Pierre, director of Carmat, said in a statement.
The procedure took place at Duke University Hospital in Durham, North Carolina, Carmat said.
Three other centers for research have been established in the United States and are in the process of selecting test candidates.
Ten eligible patients should be recruited for a US Food and Drug Administration-approved study.
Carmat devices are intended for people with end-stage heart failure who can usually only be treated with a heart transplant.
Related Posts
- 42Researchers at the University of Massachusetts Amherst recently unveiled their discovery of a new process for making RNA. The resulting RNA is purer, more copious and likely to be more cost-effective than any previous process could manage. This new technique removes the largest stumbling block on the path to next-generation…
- 38Human spaceflight has been fascinating man for centuries, representing the intangible need to explore the unknown, challenge new frontiers, advance technology and push scientific boundaries further. A key aspect of long-term human spaceflight is the physiological response and the consequent microgravity (0G) adaptation, which has all the features of accelerated…
- 38A study of nearly 108,000 people has found that people who regularly drink a modest amount of alcohol are at increased risk of atrial fibrillation, a condition where the heart beats in an abnormal rhythm. The study, published today (Wednesday) in the European Heart Journal, found that, compared to drinking no…
- 38Long black, espresso, or latte, whatever your coffee preference, drink too much and you could be in hot water, especially when it comes to heart health. In a world first genetic study, researchers from the Australian Centre for Precision Health at the University of South Australia found that that long-term,…
- 36Researchers at Penn Medicine have identified more genetic mutations that strongly predispose younger, otherwise healthy women to peripartum cardiomyopathy (PPCM), a rare condition characterized by weakness of the heart muscle that begins sometime during the final month of pregnancy through five months after delivery. PPCM can cause severe heart failure…